ExodusPoint Capital Management LP Makes New Investment in Cencora, Inc. $COR

ExodusPoint Capital Management LP purchased a new position in shares of Cencora, Inc. (NYSE:COR) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 48,814 shares of the company’s stock, valued at approximately $16,487,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. AustralianSuper Pty Ltd acquired a new stake in shares of Cencora in the 3rd quarter valued at $26,191,000. Chilton Investment Co. Inc. acquired a new stake in shares of Cencora in the 3rd quarter valued at $459,000. Lansforsakringar Fondforvaltning AB publ boosted its stake in shares of Cencora by 5.4% in the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 60,254 shares of the company’s stock valued at $18,831,000 after purchasing an additional 3,073 shares in the last quarter. Nordea Investment Management AB boosted its stake in shares of Cencora by 3.8% in the 4th quarter. Nordea Investment Management AB now owns 1,256,356 shares of the company’s stock valued at $426,715,000 after purchasing an additional 45,712 shares in the last quarter. Finally, Assetmark Inc. boosted its stake in shares of Cencora by 57.0% in the 4th quarter. Assetmark Inc. now owns 67,281 shares of the company’s stock valued at $22,724,000 after purchasing an additional 24,431 shares in the last quarter. Institutional investors and hedge funds own 97.52% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the stock. Barclays reduced their target price on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 10th. William Blair assumed coverage on shares of Cencora in a research note on Tuesday, April 28th. They issued a “market perform” rating on the stock. Robert W. Baird reduced their target price on shares of Cencora from $420.00 to $339.00 and set an “outperform” rating on the stock in a research note on Thursday, May 7th. UBS Group lifted their price target on Cencora from $410.00 to $412.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, Morgan Stanley set a $342.00 price target on Cencora in a report on Friday, May 8th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $374.00.

Cencora Stock Performance

Cencora stock opened at $281.22 on Wednesday. The stock has a 50-day simple moving average of $287.49 and a 200 day simple moving average of $326.05. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The stock has a market capitalization of $54.71 billion, a price-to-earnings ratio of 21.57, a P/E/G ratio of 1.52 and a beta of 0.59.

Cencora (NYSE:COR) last released its quarterly earnings results on Wednesday, May 6th. The company reported $4.75 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.82 by ($0.07). Cencora had a net margin of 0.78% and a return on equity of 135.20%. The business had revenue of $78.36 billion during the quarter, compared to the consensus estimate of $81.09 billion. During the same period in the prior year, the firm earned $4.42 earnings per share. The business’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. On average, research analysts anticipate that Cencora, Inc. will post 17.79 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were issued a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s payout ratio is currently 18.40%.

Cencora announced that its Board of Directors has authorized a stock buyback program on Thursday, May 21st that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.